Stephen Huhn
Director Técnico/Científico/I+D en CONTINEUM THERAPEUTICS, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Stephen Huhn
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2020 | - |
Historial de carrera de Stephen Huhn
Antiguos cargos conocidos de Stephen Huhn.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Director Técnico/Científico/I+D | 17/06/2014 | 01/01/2016 |
| Corporate Officer/Principal | 01/01/2007 | 17/06/2014 | |
| Stanford University | Corporate Officer/Principal | - | - |
Formación de Stephen Huhn.
| University of Arizona | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Stephen Huhn
- Experiencia
